摘要 |
The invention relates to a method for the diagnosis, and/or risk stratification, and/or outcome prognosis of cardiac insufficiency for NYHA I patients, wherein a determination of the proANP marker, NT-proANP marker, or fragments or partial peptides thereof is carried out parallel to a determination of BNP, proBNP, and/or NT-proBNP on patients to be examined. |
申请人 |
BRAHMS AKTIENGESELLSCHAFT;BERGMANN, ANDREAS;MORGENTHALER, NILS;PAPASSOTIRIOU, JANA;STRUCK, JOACHIM;ANKER, STEFAN |
发明人 |
BERGMANN, ANDREAS;MORGENTHALER, NILS;PAPASSOTIRIOU, JANA;STRUCK, JOACHIM;ANKER, STEFAN |